Longer Gaps Between Tarlatamab Doses Show Promise in Small Cell Lung Cancer
The randomized Phase 2 DeLLphi-309 study found that extended-interval tarlatamab dosing every three or four weeks produced efficacy, safety and ...
Tag: chemotherapy resistance
VALD-3 Triggers Pyroptosis in Triple-Negative Breast Cancer Through ROS/JNK/Bax Pathway
A synthetic compound derived from a family of molecules first described in the nineteenth century is emerging as a surprising ...
Pancreatic cancer organoids uncover genes driving chemotherapy resistance
Pancreatic ductal adenocarcinoma remains one of the most lethal malignancies in modern oncology, with five-year survival rates that have barely ...
Cannabinoids Suppress Chemotherapy- and Radiation-Induced Death in Glioblastoma Cells
Glioblastoma is among the most aggressive and difficult-to-treat brain cancers, and a new study is drawing attention to an unexpected ...
LIG1 Loss Reveals Targetable Weakness Against Chemotherapy-Resistant Triple-Negative Breast Cancer
In triple-negative breast cancer (TNBC) that carries TP53 mutations, loss of one copy of the DNA ligase I gene (LIG1) ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!